Abstract
ObjectivesCellular immunity against BK polyomavirus (BKV)‐encoded antigens plays a crucial role in long‐term protection against virus‐associated pathogenesis in transplant recipients. However, in‐depth understanding on dynamics of these cellular immune responses is required to develop better immune monitoring and immunotherapeutic strategies.MethodsHere, we have conducted a proteome‐wide analysis of BKV‐specific T‐cell responses in a cohort of 53 healthy individuals and 26 kidney transplant recipients to delineate the functional and transcriptional profile of these effector cells and compared these characteristics to T cells directed against cytomegalovirus, which is also known to cause significant morbidity in transplant recipients.ResultsProfiling of BKV‐specific CD4+ and CD8+ T cells revealed that kidney transplant recipients with high levels of circulating viraemia showed significantly reduced T‐cell reactivity against large T and/or small T antigens when compared to healthy donors. Interestingly, T cells specific for these antigens showed strong cross‐recognition to orthologous JC virus (JCV) peptides, including those exhibiting varying degrees of sequence identity. Ex vivo functional and phenotypic characterisation revealed that the majority of BKV‐specific T cells from renal transplant recipients expressed low levels of the key transcriptional regulators T‐bet and eomesodermin, which was coincident with undetectable expression of granzyme B and perforin. However, in vitro stimulation of T cells with BKV epitopes selectively enhanced the expression of T‐bet, granzyme B and cellular trafficking molecules (CCR4, CD49d and CD103) with minimal change in eomesodermin and perforin.ConclusionsThese observations provide an important platform for the future development of immune monitoring and adoptive T‐cell therapy strategies for BKV‐associated diseases in transplant recipients, which may also be exploited for similar therapeutic value in JCV‐associated clinical complications.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
